- ►diabetesjournals.org [PDF] SJ Micallef, ME Janes, K Knezevic, RP Davis, … - Diabetes, 2005 - Am Diabetes Assoc CD4 + CD25 + T-cells can be used to interfere with spon- taneous autoimmune
diseases such as type 1 diabetes. However, their low frequency and often unknown
spec- ificity represent major obstacles to their therapeutic use. Here we ... Cited by 53 - Related articles - All 5 versions
- ►alphamedpress.org Y Shi, L Hou, F Tang, W Jiang, P Wang, M … - Stem Cells, 2005 - AlphaMed Press Experimental induction of embryonic stem cells (ESCs) to become pancreatic ß
cells can potentially provide ample resource for cell transplantation therapy of
type I diabetes mellitus. Most of the previously reported induction ... Cited by 96 - Related articles - All 6 versions
E Jaeckel, H von Boehmer, MP Manns - Diabetes, 2005 - Am Diabetes Assoc CD4 + CD25 + T-cells can be used to interfere with spontaneous autoimmune
diseases such as type 1 diabetes. However, their low frequency and often unknown
specificity represent major obstacles to their therapeutic use. Here we ... Cited by 124 - Related articles - All 5 versions
- ►diabetesjournals.org S Miyazaki, E Yamato, J Miyazaki - Diabetes, 2004 - Am Diabetes Assoc Embryonic stem (ES) cells can differentiate into many cell types. Recent reports
have shown that ES cells can differentiate into insulin-producing cells.
However, the differentiation is not efficient enough to produce insulin- ... Cited by 155 - Related articles - BL Direct - All 4 versions
P Blyszczuk, C Asbrand, A Rozzo, G Kania, … - Int J Dev Biol, 2004 - ijdb.ehu.es ABSTRACT We present a new strategy for the differentiation of embryonic stem
(ES) cells into insulin-producing cells via a multi-step process without
selection and induction of nestin-positive cells. During ES cell ... Cited by 66 - Related articles - View as HTML - All 6 versions
G Kania, P Blyszczuk, AM Wobus - Int J Dev Biol, 2004 - ijdb.ehu.es ABSTRACT The derivation of insulin-producing cells from embryonic stem (ES)
cells has been controversially described. Whereas several authors showed
successful differentiation of mouse ES cells into islet-like clusters, ... Cited by 35 - Related articles - View as HTML - All 7 versions
M Hansson, A Tonning, U Frandsen, A Petri, J … - Diabetes, 2004 - Am Diabetes Assoc Several recent reports claim the generation of insulin-producing cells from
embryonic stem cells via the differentiation of progenitors that express nestin.
Here, we investigate further the properties of these insulin-containing ... Cited by 139 - Related articles - BL Direct - All 4 versions
BW Kahan, LM Jacobson, DA Hullett, JM … - Diabetes, 2003 - Am Diabetes Assoc Embryonic stem (ES) cells differentiating in vitro reproduce many facets of
early embryonic development, including the expression of developmentally
regulated transcription factors and the differentiation of multipotent ... Cited by 101 - Related articles - BL Direct - All 6 versions
N Shiraki, CJ Lai, Y Hishikari, S Kume - Genes to Cells, 2005 - Mol Biology Soc Japan Embryonic stem (ES) cells have the capacity to differentiate to every cell type
that constitutes fetal or adult tissues. To trace and quantitatively assess the
differentiation of ES cells into gut endodermal cells, we used an ES cell ... Cited by 16 - Related articles - All 5 versions
S Sipione, A Eshpeter, JG Lyon, GS Korbutt, … - Diabetologia, 2004 - Springer Aim/hypothesis. Embryonic stem (ES) cells have been proposed as a potential
source of tissue for transplan- tation for the treatment of Type 1 diabetes.
However, studies showing differentiation of beta cells from ES cells are ... Cited by 123 - Related articles - BL Direct - All 6 versions
